Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CMPX | Common Stock, $.0001 Par Value | Other | +1.79M | 1.79M | Jun 25, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CMPX | Stock Option (Right to Buy) | Award | $0 | +50K | $0.00 | 50K | Jun 25, 2021 | Common Stock, $.0001 Par Value | 50K | $4.90 | Direct | F2 |
Id | Content |
---|---|
F1 | The reporting person acquired 1,791,549 shares of the issuer's common stock as consideration in connection with the acquisition of TRIGR Therapeutics, Inc. by the issuer. The merger agreement, which was entered into on May 13, 2021, placed a negotiated value on the issuer's common stock of $5.85 a share. Of the 1,791,549 shares issued to the reporting person in the merger, 283,648 shares are currently being held in escrow and are subject to forfeiture for the purposes described in the merger agreement. |
F2 | The option has a term of 10 years and vest in equal monthly installments over the 48 month period commencing on July 25, 2021. |